Pfizer Reports Increased Profits; Beats Estimates (PFE)

Pfizer Reports Increased Profits; Beats Estimates (PFE)


Biopharmaceutical company, Pfizer Inc.(PFE) reported Q4 earnings that showed a significant increase in profit, beating analysts expectations on Tuesday.

The New York, NY based company reported fourth quarter earnings of $6.32 billion, or 86 cents per share, up 77% from $1.44 billion, or 19 cents per share last year. Excluding special items, the company reported earnings of 47 cents per share, beating analysts estimate of 44 cents per share.

Increased profits were partially a result of a $12 billion sale in November for its nutritional products business to Swiss food groups Nestle SA.

PFE saw a -7% decrease in revenue during the quarter, reporting sales of $15.1 billion. Analysts expected to see still-lower revenue of $14.37 billion. Revenue declined due to increased competition in some key markets.

For the full year 2013, the company estimates earnings in the range of $2.20 to $2.30 per share. Analysts are expecting EPS of $2.29.

Pfizer shares were mostly flat during premarket trading Tuesday. The stock has increased 25% in the past year.

The Bottom Line
Shares of Pfizer Inc.(PFE) have a 3.58% yield, based on Monday’s closing stock price of $26.84.

Pfizer Inc.(PFE) is a “Recommended” dividend stock, holding a DARS™ Rating of 3.5 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.

Free Updates

Join over 100,000 investors who get the latest news from

Best Dividend Stocks

Looking for stocks that are poised for growth and pay solid dividends? Visit our list of the:

Best Dividend Stocks

Partner Center

Best CD Rates

Sitting on some extra cash and looking for the most current and profitable CD Rates?

Get The Best CD Rates

14 Day Free Trial

Earn more from your dividend portfolio within the next 14 days.

Sign Up Today